• General
  • Industry
  • Government & Politics
  • Other Language
  • Press Release
  • Home
  • Submit News
  • Contact Us
  • About Us
Pakistan Newswire
Menu
  • General
  • Industry
  • Government & Politics
  • Other Language
  • Press Release
 › Medical/Health Care › Urdu News › Novel Flavonoid Compounds That Significantly Reduce Cancer Cell Growth Are Available For Further Research and Development as Anti-Cancer Therapeutics

Novel Flavonoid Compounds That Significantly Reduce Cancer Cell Growth Are Available For Further Research and Development as Anti-Cancer Therapeutics

Web Desk August 16, 2011     No Comment     Medical/Health Care, Urdu News

AsiaNet 45924

PERTH, Aug 16, 2011/Medianet International-AsiaNet/–

Australian based Heartlink Limited is developing proprietary synthetic compounds based on the isoflavone structure that have demonstrated anti-cancer efficacy in both laboratory and animal studies at low dosage levels. Compounds tested to date show low levels of toxicity vs normal mammalian cells.

The initial in-vitro drug screen study revealed activity of the selected compounds against a panel of nine human cancer cell lines using a standard cell proliferation assay procedure. The affirmative results demonstrated dramatic anti-proliferative and cytotoxic effects against a range of tumour cell lines (with the highest activity against prostate and cervical cancer) following treatment with three of the Company’s proprietary compounds.

A subsequent in-vivo study designed to test the effectiveness of two test compounds against tumours also had a positive outcome. Compounds were tested for their anti-cancer activity at a range of doses in a mouse model employing human prostate cancer cells. Results showed a substantial 42% reduction in tumour growth relative to controls after 14 days of treatment at low dosage levels(10 mg/kg).

Isoflavonoids are known to have anti-cancer activity particularly in hormone-based cancers such as ovarian, breast and prostate. Heartlink has identified, evaluated and patented a family of isoflavone related compounds. The patents cover a wide range of therapeutic uses and details the specific pathways for production and manufacture alongside potential formulations for therapeutic use.

According to Heartlink CEO, Tracey-Anne Dickens, “Research activities to-date have provided valuable pre-clinical data for the development of this family of isoflavonoid compounds that could prove a useful source for the development of anti-cancer medicines. Data collected provides a basis on which to further develop the proprietary compounds and as such, we are actively seeking alliances for research and development or commercialisation.”

About Heartlink Limited
The Company was incorporated in January 2000. The Company has funded clinical research and product development and now has a second-generation medical device that can be used for research and development applications. Heartlink is also a drug discovery Company and has identified and patented anti-cancer compounds derived from isoflavonoid compounds. Pre-clinical studies on the Company’s proprietary compounds have demonstrated significant activity that provides a basis for further evaluation of these novel anti-cancer therapeutics.

More Information
Tracey-Anne Dickens
Chief Executive Officer
Heartlink Limited
Western Australia
Telephone +61 8 9389 9021
tracey@heartlink.com.au

SOURCE: Heartlink Limited

Medical/Health Care Urdu News
Heartlink LimitedMedical/Health Care

 Previous Post

AKD Quotidian about — ENGRO: 1HCY11 Analyst Briefing Update

― August 16, 2011

Next Post 

Panama Canal to Host First-Ever International Engineering and Infrastructure Congress

― August 16, 2011

Related Articles

AsiaNet Pakistan ― January 21, 2021 | Comment Closed

‫نینو،30 ټائمز په ذریعہ زیفیرټیل د حل په ذریعہ د مواد فراہمی ګړندې کوې۔

بھوټان آئی ایس پی صارفین د تجربے له بہتر جوړوې او طویل مدتی اسټټریټجک شراکت سره اولسې اوریځ اړخ ته ګورې۔ لندن ، 21 جنوری ، 2021 / پی آر نیوز وائیر / – عالمی ټیلی مواصلات آپریټرز خدمت کونکې داولسې اوریځ حل فراہم کونکې ، زیفیرټیل په بھوټان کښې انټرنیټ سروس فراہم کونکې  (آئی […]

AsiaNet Pakistan ― January 21, 2021 | Comment Closed

‫جیمن کئیر نے anti-SARS-CoV-2 کو بے اثر کرنے والی اینٹی باڈی JMB2002 کے طبی تجربے کے پہلے مرحلے کا آغاز کردیا

AsiaNet Pakistan ― January 21, 2021 | Comment Closed

‫نانو نے زیفیرٹیل کے حل کے ہمراہ مواد کی فراہمی کی رفتار30 گُنا بڑھادی

AsiaNet Pakistan ― January 21, 2021 | Comment Closed

پھولو ایک پاکسنانی کسان جس کے لاکھوں پرستار ہے نے ابھی سنیک ویڈیو جائن کیا

AsiaNet Pakistan ― January 14, 2021 | Comment Closed

ینگ شینگ اناج اور تیل کی مہم ٹائمز اسکوائر، نیو یارک، یو ایس اے میں نشر

AsiaNet Pakistan ― January 13, 2021 | Comment Closed

‫ٹی سی ایل کی جانب سے سی ای ایس 2021 کے موقع پر مختلف کیٹیگریز میں نئی مصنوعات کی رونمائی- ٹی وی ،آڈیو،موبائل اور جدید گھریلو مصنوعات

AsiaNet Pakistan ― January 13, 2021 | Comment Closed

سنیک ویڈو نے افتتاحی مواد کے ساتھ پاکستان میں اپنی پہلی تخلیق کار یعنی افتیتاحی کنٹینٹ اکیڈمی کی شروعات کردی ہیں

AsiaNet Pakistan ― January 12, 2021 | Comment Closed

سی آر آر سی نے آسٹریلیا میں چینی ثقافتی لائبریریاں قائم کردیں

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search

Monthly Archives

Follow Us

Pages

  • Home
  • Submit News
  • Contact Us
  • About Us

Advertisement

Calendar

January 2021
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec    


The strategy of the team behind “Pakistan news Wire.Net” is clear and it is to publish only authentic news as that is what the true journalism demands from any media outlet, and the “Pakistan News Wire. Net”, discourages the practice of opting for illegal approaches in order to get the ratings by any means. The more media outlets opt [...]

Archives

Search

Categories

  • General
  • Industry
  • Government & Politics
  • Other Language
  • Press Release
Copyright © 2020 - Pakistan News Wire. All Rights Reserved.